{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:01:01Z","timestamp":1787029261898,"version":"build-2736575974"},"reference-count":202,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chinese National Natural Science Fund","award":["81902947"],"award-info":[{"award-number":["81902947"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Undesirable side effects and multidrug resistance are the major obstacles in conventional chemotherapy towards cancers. Nanomedicines provide alternative strategies for tumor-targeted therapy due to their inherent properties, such as nanoscale size and tunable surface features. However, the applications of nanomedicines are hampered in vivo due to intrinsic disadvantages, such as poor abilities to cross biological barriers and unexpected off-target effects. Fortunately, biomimetic nanomedicines are emerging as promising therapeutics to maximize anti-tumor efficacy with minimal adverse effects due to their good biocompatibility and high accumulation abilities. These bioengineered agents incorporate both the physicochemical properties of diverse functional materials and the advantages of biological materials to achieve desired purposes, such as prolonged circulation time, specific targeting of tumor cells, and immune modulation. Among biological materials, mammalian cells (such as red blood cells, macrophages, monocytes, and neutrophils) and pathogens (such as viruses, bacteria, and fungi) are the functional components most often used to confer synthetic nanoparticles with the complex functionalities necessary for effective nano-biointeractions. In this review, we focus on recent advances in the development of bioinspired and biomimetic nanomedicines (such as mammalian cell-based drug delivery systems and pathogen-based nanoparticles) for targeted cancer therapy. We also discuss the biological influences and limitations of synthetic materials on the therapeutic effects and targeted efficacies of various nanomedicines.<\/jats:p>","DOI":"10.3390\/pharmaceutics14051109","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T03:16:55Z","timestamp":1653362215000},"page":"1109","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Bioinspired and Biomimetic Nanomedicines for Targeted Cancer Therapy"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-7725","authenticated-orcid":false,"given":"Xiaoqiu","family":"Xu","sequence":"first","affiliation":[{"name":"Laboratory of Human Diseases and Immunotherapies, West China Hospital, Sichuan University, Chengdu 610041, China"},{"name":"Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory of Human Diseases and Immunotherapies, West China Hospital, Sichuan University, Chengdu 610041, China"},{"name":"State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-3440","authenticated-orcid":false,"given":"Ke","family":"Jin","sequence":"additional","affiliation":[{"name":"Laboratory of Human Diseases and Immunotherapies, West China Hospital, Sichuan University, Chengdu 610041, China"},{"name":"Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: Progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"119791","DOI":"10.1016\/j.biomaterials.2020.119791","article-title":"Targeted camptothecin delivery via silicon nanoparticles reduces breast cancer metastasis","volume":"240","author":"Landgraf","year":"2020","journal-title":"Biomaterials"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects","volume":"3","author":"Florea","year":"2011","journal-title":"Cancers"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14656566.4.6.889","article-title":"Toxicity of platinum compounds","volume":"4","author":"Hartmann","year":"2003","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10555-013-9447-3","article-title":"Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch","volume":"32","author":"Baldo","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1039\/C9TB00594C","article-title":"Novel lignin nanoparticles for oral drug delivery","volume":"7","author":"Alqahtani","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0611610104","article-title":"Probing the interactions of proteins and nanoparticles","volume":"104","author":"Klein","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101022","DOI":"10.1016\/j.nantod.2020.101022","article-title":"Ultrasound-enhanced precision tumor theranostics using cell membrane-coated and pH-responsive nanoclusters assembled from ultrasmall iron oxide nanoparticles","volume":"36","author":"Jia","year":"2021","journal-title":"Nano Today"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties","volume":"42","author":"Moghimi","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.biomaterials.2017.03.011","article-title":"Long-term bioavailability of redox nanoparticles effectively reduces organ dysfunctions and death in whole-body irradiated mice","volume":"129","author":"Feliciano","year":"2017","journal-title":"Biomaterials"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phrs.2016.11.014","article-title":"Tumor-targeted nanomedicines for cancer theranostics","volume":"115","author":"Arranja","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","author":"Sulheim","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"ref_18","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.01.002","article-title":"Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity","volume":"91","author":"Maeda","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: Strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1021\/nn500299p","article-title":"Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency","volume":"8","author":"Sykes","year":"2014","journal-title":"ACS Nano"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.7150\/thno.37198","article-title":"Alliance with EPR effect: Combined strategies to improve the EPR effect in the tumor microenvironment","volume":"9","author":"Park","year":"2019","journal-title":"Theranostics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1021\/acs.nanolett.1c00818","article-title":"Tumor-associated-macrophage-membrane-coated nanoparticles for improved photodynamic immunotherapy","volume":"21","author":"Chen","year":"2021","journal-title":"Nano Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1705436","DOI":"10.1002\/adma.201705436","article-title":"Dimeric drug polymeric micelles with acid-active tumor targeting and FRET-traceable drug release","volume":"30","author":"Guo","year":"2018","journal-title":"Adv. Mater."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.colsurfb.2017.11.015","article-title":"The effects of ligand valency and density on the targeting ability of multivalent nanoparticles based on negatively charged chitosan nanoparticles","volume":"161","author":"Cao","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2000512","DOI":"10.1002\/adma.202000512","article-title":"Biomedical micro-\/nanomotors: From overcoming biological barriers to in vivo imaging","volume":"33","author":"Gao","year":"2021","journal-title":"Adv. Mater."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Cojocaru, F.-D., Botezat, D., Gardikiotis, I., Uritu, C.-M., Dodi, G., Trandafir, L., Rezus, C., Rezus, E., Tamba, B.-I., and Mihai, C.-T. (2020). Nanomaterials designed for antiviral drug delivery transport across biological barriers. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12020171"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2018.02.043","article-title":"Bacteria-like mesoporous silica-coated gold nanorods for positron emission tomography and photoacoustic imaging-guided chemo-photothermal combined therapy","volume":"165","author":"Xu","year":"2018","journal-title":"Biomaterials"},{"key":"ref_30","first-page":"4402","article-title":"Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma","volume":"6","author":"Fan","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/smll.201201390","article-title":"Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking","volume":"9","author":"Duan","year":"2013","journal-title":"Small"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1021\/acsnano.5b02017","article-title":"The role of micelle size in tumor accumulation, penetration, and treatment","volume":"9","author":"Wang","year":"2015","journal-title":"ACS Nano"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"19048","DOI":"10.1073\/pnas.1315336110","article-title":"Photoswitchable nanoparticles for in vivo cancer chemotherapy","volume":"110","author":"Tong","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15344","DOI":"10.1073\/pnas.1411499111","article-title":"Investigating the optimal size of anticancer nanomedicine","volume":"111","author":"Tang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/ange.201711354","article-title":"Near-Infrared Triggered Decomposition of Nanocapsules with High Tumor Accumulation and Stimuli Responsive Fast Elimination","volume":"130","author":"Zhao","year":"2018","journal-title":"Angew. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrc.2017.93","article-title":"Transport of drugs from blood vessels to tumour tissue","volume":"17","author":"Dewhirst","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/acscentsci.9b01139","article-title":"Size-tunable strategies for a tumor targeted drug delivery system","volume":"6","author":"Yu","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1021\/nn402201w","article-title":"Enhanced retention and cellular uptake of nanoparticles in tumors by controlling their aggregation behavior","volume":"7","author":"Liu","year":"2013","journal-title":"ACS Nano"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1021\/acsnano.6b05070","article-title":"Increased gold nanoparticle retention in brain tumors by in situ enzyme-induced aggregation","volume":"10","author":"Ruan","year":"2016","journal-title":"ACS Nano"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1021\/acs.biomac.8b00241","article-title":"Hemoglobin as a smart pH-sensitive nanocarrier to achieve aggregation enhanced tumor retention","volume":"19","author":"Li","year":"2018","journal-title":"Biomacromolecules"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1604894","DOI":"10.1002\/adma.201604894","article-title":"Light-triggered assembly of gold nanoparticles for photothermal therapy and photoacoustic imaging of tumors in vivo","volume":"29","author":"Cheng","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.1021\/acsnano.7b03375","article-title":"General approach of stimuli-induced aggregation for monitoring tumor therapy","volume":"11","author":"Qiao","year":"2017","journal-title":"ACS Nano"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1002\/adfm.201604206","article-title":"A sequentially triggered nanosystem for precise drug delivery and simultaneous inhibition of cancer growth, migration, and invasion","volume":"26","author":"Liu","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1701170","DOI":"10.1002\/adma.201701170","article-title":"Sequentially responsive Shell-stacked nanoparticles for deep penetration into solid tumors","volume":"29","author":"Chen","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biomaterials.2019.01.025","article-title":"A disassembling strategy overcomes the EPR effect and renal clearance dilemma of the multifunctional theranostic nanoparticles for cancer therapy","volume":"197","author":"Wang","year":"2019","journal-title":"Biomaterials"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/acscentsci.7b00257","article-title":"Facile synthesis of uniform virus-like mesoporous silica nanoparticles for enhanced cellular internalization","volume":"3","author":"Wang","year":"2017","journal-title":"ACS Cent. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11476","DOI":"10.1021\/acs.chemrev.7b00194","article-title":"Form follows function: Nanoparticle shape and its implications for nanomedicine","volume":"117","author":"Kinnear","year":"2017","journal-title":"Chem. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.1216893110","article-title":"Particle shape enhances specificity of antibody-displaying nanoparticles","volume":"110","author":"Barua","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.2174\/138161210791920496","article-title":"Factors that control the circulation time of nanoparticles in blood: Challenges, solutions and future prospects","volume":"16","author":"Yoo","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"15662","DOI":"10.1002\/ange.202004832","article-title":"Topology-matching design of an influenza-neutralizing spiky nanoparticle-based inhibitor with a dual mode of action","volume":"132","author":"Nie","year":"2020","journal-title":"Angew. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Wu, J. (2021). The enhanced permeability and retention (EPR) effect: The significance of the concept and methods to enhance its application. J. Pers. Med., 11.","DOI":"10.3390\/jpm11080771"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","article-title":"Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment","volume":"95","author":"Hobbs","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"16073","DOI":"10.1038\/natrevmats.2016.73","article-title":"Evaluation of nanomedicines: Stick to the basics","volume":"1","author":"McNeil","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"100970","DOI":"10.1016\/j.nantod.2020.100970","article-title":"Investigating the EPR effect of nanomedicines in human renal tumors via ex vivo perfusion strategy","volume":"35","author":"Ding","year":"2020","journal-title":"Nano Today"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0002-9440(10)65006-7","article-title":"Openings between defective endothelial cells explain tumor vessel leakiness","volume":"156","author":"Hashizume","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Huang, D., Sun, L., Huang, L., and Chen, Y. (2021). Nanodrug delivery systems modulate tumor vessels to increase the enhanced permeability and retention effect. J. Pers. Med., 11.","DOI":"10.3390\/jpm11020124"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/17425240903579971","article-title":"Designer nanoparticles: Incorporating size, shape and triggered release into nanoscale drug carriers","volume":"7","author":"Guimard","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1021\/acs.accounts.9b00079","article-title":"Bioinspired and biomimetic nanomedicines","volume":"52","author":"Chen","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.addr.2012.02.006","article-title":"Photochemical mechanisms of light-triggered release from nanocarriers","volume":"64","author":"Fomina","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Indermun, S., Govender, M., Kumar, P., Choonara, Y.E., and Pillay, V. (2018). Stimuli-responsive polymers as smart drug delivery systems: Classifications based on carrier type and triggered-release mechanism. Stimuli Responsive Polymeric Nanocarriers for Drug Delivery Applications, Volume 1, Elsevier.","DOI":"10.1016\/B978-0-08-101997-9.00002-3"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jconrel.2020.01.021","article-title":"Hypoxia-sensitive supramolecular nanogels for the cytosolic delivery of ribonuclease A as a breast cancer therapeutic","volume":"320","author":"Si","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.7150\/thno.64229","article-title":"Exosome-mediated delivery of inflammation-responsive Il-10 mRNA for controlled atherosclerosis treatment","volume":"11","author":"Bu","year":"2021","journal-title":"Theranostics"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1021\/nn400548g","article-title":"Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis","volume":"7","author":"Huang","year":"2013","journal-title":"ACS Nano"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1801201","DOI":"10.1002\/advs.201801201","article-title":"Enhancing Antitumor Efficacy by Simultaneous ATP-Responsive Chemodrug Release and Cancer Cell Sensitization Based on a Smart Nanoagent","volume":"5","author":"Song","year":"2018","journal-title":"Adv. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1039\/D1BM00331C","article-title":"T cell membrane cloaking tumor microenvironment-responsive nanoparticles with a smart \u201cmembrane escape mechanism\u201d for enhanced immune-chemotherapy of melanoma","volume":"9","author":"Li","year":"2021","journal-title":"Biomater. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12951-020-00649-8","article-title":"Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy","volume":"18","author":"Gong","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/nl500618u","article-title":"Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery","volume":"14","author":"Fang","year":"2014","journal-title":"Nano Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jconrel.2020.09.012","article-title":"Cell membrane coated nanocarriers-an efficient biomimetic platform for targeted therapy","volume":"327","author":"Dash","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2004397","DOI":"10.1002\/adfm.202004397","article-title":"Improving cancer immunotherapy by cell membrane-camouflaged nanoparticles","volume":"30","author":"Zeng","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12951-021-00805-8","article-title":"Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles","volume":"19","author":"Gong","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1038\/s41467-021-26052-x","article-title":"Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"28732","DOI":"10.1021\/acsami.9b10318","article-title":"Biomimetic immunomagnetic nanoparticles with minimal nonspecific biomolecule adsorption for enhanced isolation of circulating tumor cells","volume":"11","author":"Meng","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"15262","DOI":"10.1021\/acsami.9b00897","article-title":"Light\/pH-triggered biomimetic red blood cell membranes camouflaged small molecular drug assemblies for imaging-guided combinational chemo-photothermal therapy","volume":"11","author":"Ye","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"110842","DOI":"10.1016\/j.colsurfb.2020.110842","article-title":"Bioinspired red blood cell membrane-encapsulated biomimetic nanoconstructs for synergistic and efficacious chemo-photothermal therapy","volume":"189","author":"Wang","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"17442","DOI":"10.1021\/acsnano.0c07721","article-title":"Fighting immune cold and reprogramming immunosuppressive tumor microenvironment with red blood cell membrane-camouflaged nanobullets","volume":"14","author":"Yang","year":"2020","journal-title":"ACS Nano"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1021\/acs.nanolett.7b05263","article-title":"Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2147\/IJN.S288636","article-title":"Engineering of neutrophil membrane camouflaging nanoparticles realizes targeted drug delivery for amplified antitumor therapy","volume":"16","author":"Wang","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2001704","DOI":"10.1002\/smll.202001704","article-title":"Platelet Membrane-Camouflaged Magnetic Nanoparticles for Ferroptosis-Enhanced Cancer Immunotherapy","volume":"16","author":"Jiang","year":"2020","journal-title":"Small"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"12096","DOI":"10.1021\/acsnano.8b05292","article-title":"Cell-membrane immunotherapy based on natural killer cell membrane coated nanoparticles for the effective inhibition of primary and abscopal tumor growth","volume":"12","author":"Deng","year":"2018","journal-title":"ACS Nano"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jcis.2021.02.006","article-title":"Cell membrane camouflaged bismuth nanoparticles for targeted photothermal therapy of homotypic tumors","volume":"591","author":"Ren","year":"2021","journal-title":"J. Colloid Interface Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1038\/s41467-020-18626-y","article-title":"Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis","volume":"11","author":"Rao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biomaterials.2018.11.021","article-title":"Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal therapy efficacy in tumors","volume":"192","author":"Jiang","year":"2019","journal-title":"Biomaterials"},{"key":"ref_85","first-page":"958","article-title":"Long circulating nanoparticles via adhesion on red blood cells: Mechanism and extended circulation","volume":"232","author":"Chambers","year":"2007","journal-title":"Exp. Biol. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1805557","DOI":"10.1002\/adma.201805557","article-title":"Nanoparticle-laden macrophages for tumor-tropic drug delivery","volume":"30","author":"Zhang","year":"2018","journal-title":"Adv. Mater."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nbt.4181","article-title":"Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery","volume":"36","author":"Tang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1606617","DOI":"10.1002\/adma.201606617","article-title":"Red blood cells for glucose-responsive insulin delivery","volume":"29","author":"Wang","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Glassman, P.M., Villa, C.H., Ukidve, A., Zhao, Z., Smith, P., Mitragotri, S., Russell, A.J., Brenner, J.S., and Muzykantov, V.R. (2020). Vascular drug delivery using carrier red blood cells: Focus on RBC surface loading and pharmacokinetics. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12050440"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-bioeng-121219-024239","article-title":"Red blood cell hitchhiking: A novel approach for vascular delivery of Nanocarriers","volume":"23","author":"Brenner","year":"2021","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/17425241003610633","article-title":"Drug delivery by red blood cells: Vascular carriers designed by mother nature","volume":"7","author":"Muzykantov","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2100088","DOI":"10.1002\/adfm.202100088","article-title":"Cell-based delivery systems: Emerging carriers for immunotherapy","volume":"31","author":"Li","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1021\/nn404853z","article-title":"Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells","volume":"7","author":"Anselmo","year":"2013","journal-title":"ACS Nano"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2003.11.018","article-title":"Drug, enzyme and peptide delivery using erythrocytes as carriers","volume":"95","author":"Millan","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"863","DOI":"10.7150\/thno.11852","article-title":"Cell or cell membrane-based drug delivery systems","volume":"5","author":"Tan","year":"2015","journal-title":"Theranostics"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"121202","DOI":"10.1016\/j.biomaterials.2021.121202","article-title":"Clinical progress and advanced research of red blood cells based drug delivery system","volume":"279","author":"Li","year":"2021","journal-title":"Biomaterials"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2013.12.019","article-title":"Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application","volume":"176","author":"He","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s10439-019-02342-w","article-title":"Shear-induced encapsulation into red blood cells: A new microfluidic approach to drug delivery","volume":"48","author":"Piergiovanni","year":"2020","journal-title":"Ann. Biomed. Eng."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jconrel.2004.08.005","article-title":"Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes","volume":"100","author":"Chambers","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/s41467-018-05079-7","article-title":"Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude","volume":"9","author":"Brenner","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1039\/C8NR07730D","article-title":"Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth","volume":"11","author":"Zelepukin","year":"2019","journal-title":"Nanoscale"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1021\/acscentsci.9b01235","article-title":"M2-like tumor-associated macrophage-targeted codelivery of STAT6 inhibitor and IKK\u03b2 siRNA induces M2-to-M1 repolarization for cancer immunotherapy with low immune side effects","volume":"6","author":"Xiao","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"eaaz6579","DOI":"10.1126\/sciadv.aaz6579","article-title":"Cellular backpacks for macrophage immunotherapy","volume":"6","author":"Shields","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1701021","DOI":"10.1002\/adma.201701021","article-title":"Photosensitization priming of tumor microenvironments improves delivery of nanotherapeutics via neutrophil infiltration","volume":"29","author":"Chu","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"120021","DOI":"10.1016\/j.biomaterials.2020.120021","article-title":"Dual-engineered,\u201cTrojanized\u201d macrophages bio-modally eradicate tumors through biologically and photothermally deconstructing cancer cells in an on-demand, NIR-commanded, self-explosive manner","volume":"250","author":"Huang","year":"2020","journal-title":"Biomaterials"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.7150\/thno.33141","article-title":"An in situ microenvironmental nano-regulator to inhibit the proliferation and metastasis of 4T1 tumor","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the tumor microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fonc.2018.00049","article-title":"Targeting macrophages in cancer: From bench to bedside","volume":"8","author":"Poh","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nnano.2014.62","article-title":"Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery","volume":"9","author":"Smith","year":"2014","journal-title":"Nat. Nanotechnol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"115435","DOI":"10.1016\/j.carbpol.2019.115435","article-title":"Selective uptake of chitosan polymeric micelles by circulating monocytes for enhanced tumor targeting","volume":"229","author":"Yang","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2014.11.027","article-title":"Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: A generalized strategy to deliver drugs to treat inflammation","volume":"199","author":"Anselmo","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nri.2016.49","article-title":"Neutrophil migration in infection and wound repair: Going forward in reverse","volume":"16","author":"Rosowski","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.it.2010.05.006","article-title":"Neutrophil kinetics in health and disease","volume":"31","author":"Summers","year":"2010","journal-title":"Trends Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: Differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1152\/physrev.00012.2018","article-title":"The neutrophil\u2019s role during health and disease","volume":"99","author":"Liew","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.apsb.2017.11.009","article-title":"Cell membrane-based nanoparticles: A new biomimetic platform for tumor diagnosis and treatment","volume":"8","author":"Li","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_117","first-page":"879","article-title":"Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy","volume":"3","author":"Yaman","year":"2020","journal-title":"Cancer Drug Resist."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrc3672","article-title":"Thermal ablation of tumours: Biological mechanisms and advances in therapy","volume":"14","author":"Chu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2019.05.036","article-title":"Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma","volume":"306","author":"Zhang","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41467-020-14963-0","article-title":"Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1073\/pnas.0405193102","article-title":"Myeloperoxidase mediates neutrophil activation by association with CD11b\/CD18 integrins","volume":"102","author":"Lau","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1172\/JCI38591","article-title":"Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell\u2013derived lin\u2013CD34+ CD43+ CD45+ progenitors","volume":"119","author":"Choi","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41467-017-00729-8","article-title":"Bacterial outer membrane vesicles suppress tumor by interferon-\u03b3-mediated antitumor response","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1021\/acs.nanolett.7b05323","article-title":"Bacteria-mediated tumor therapy utilizing photothermally-controlled TNF-\u03b1 expression via oral administration","volume":"18","author":"Fan","year":"2018","journal-title":"Nano Lett."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.addr.2020.06.024","article-title":"Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications","volume":"156","author":"Chung","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3389\/fphar.2019.00751","article-title":"Bioinspired and biomimetic nanotherapies for the treatment of infectious diseases","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.actbio.2018.04.023","article-title":"Development of a macrophage-targeting and phagocytosis-inducing bio-nanocapsule-based nanocarrier for drug delivery","volume":"73","author":"Li","year":"2018","journal-title":"Acta Biomater."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrd3499","article-title":"Bio-inspired, bioengineered and biomimetic drug delivery carriers","volume":"10","author":"Yoo","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_130","unstructured":"Gelderblom, H.R. (1996). Structure and classification of viruses. Medical Microbiology, University of Texas Medical Branch at Galveston. [4th ed.]. Chapter 41."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.280.5361.248","article-title":"Viral strategies of immune evasion","volume":"280","author":"Ploegh","year":"1998","journal-title":"Science"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1111\/febs.13274","article-title":"Rethinking the capsid proteins of enveloped viruses: Multifunctionality from genome packaging to genome transfection","volume":"282","author":"Freire","year":"2015","journal-title":"FEBS J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2001238","DOI":"10.1002\/adhm.202001238","article-title":"Is viral vector gene delivery more effective using biomaterials?","volume":"10","author":"Wang","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/83324","article-title":"Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics","volume":"7","author":"Kay","year":"2001","journal-title":"Nat. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cbpa.2017.03.013","article-title":"Plant viruses and bacteriophages for drug delivery in medicine and biotechnology","volume":"38","author":"Czapar","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Hefferon, K.L. (2018). Repurposing plant virus nanoparticles. Vaccines, 6.","DOI":"10.3390\/vaccines6010011"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1700991","DOI":"10.1002\/advs.201700991","article-title":"Slow-release formulation of cowpea mosaic virus for in situ vaccine delivery to treat ovarian cancer","volume":"5","author":"Czapar","year":"2018","journal-title":"Adv. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1021\/acs.molpharmaceut.7b00466","article-title":"Tobacco mosaic virus-delivered cisplatin restores efficacy in platinum-resistant ovarian cancer cells","volume":"15","author":"Franke","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1908743","DOI":"10.1002\/adfm.201908743","article-title":"The antitumor efficacy of CpG oligonucleotides is improved by encapsulation in plant virus-like particles","volume":"30","author":"Cai","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1021\/acs.nanolett.9b00679","article-title":"Cargo-compatible encapsulation in virus-based nanoparticles","volume":"19","author":"Li","year":"2019","journal-title":"Nano Lett."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1021\/bc100361z","article-title":"The Red clover necrotic mosaic virus capsid as a multifunctional cell targeting plant viral nanoparticle","volume":"22","author":"Lockney","year":"2011","journal-title":"Bioconjugate Chem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"10420","DOI":"10.1039\/C7NR03018E","article-title":"Modular interior loading and exterior decoration of a virus-like particle","volume":"9","author":"Sharma","year":"2017","journal-title":"Nanoscale"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1021\/acschembio.6b00060","article-title":"Chemically modifying viruses for diverse applications","volume":"11","author":"Mohan","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s40425-019-0587-z","article-title":"Vaccination with nanoparticles combined with micro-adjuvants protects against cancer","volume":"7","author":"Mohsen","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"101119","DOI":"10.1016\/j.nantod.2021.101119","article-title":"Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy","volume":"38","author":"Delfi","year":"2021","journal-title":"Nano Today"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/mt.2009.41","article-title":"Biological gene delivery vehicles: Beyond viral vectors","volume":"17","author":"Seow","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","article-title":"Hepatitis B virus infection initiates with a large surface protein\u2013dependent binding to heparan sulfate proteoglycans","volume":"46","author":"Schulze","year":"2007","journal-title":"Hepatology"},{"key":"ref_148","first-page":"122","article-title":"Role of glycosaminoglycans for binding and infection of hepatitis B virus","volume":"10","author":"Leistner","year":"2008","journal-title":"Cell. Microbiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hep.26211","article-title":"Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts","volume":"58","author":"Schieck","year":"2013","journal-title":"Hepatology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"12992","DOI":"10.1128\/JVI.76.24.12992-13000.2002","article-title":"Oligosaccharides as receptors for JC virus","volume":"76","author":"Komagome","year":"2002","journal-title":"J. Virol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/s41598-018-19825-w","article-title":"Gene therapy for human glioblastoma using neurotropic JC virus-like particles as a gene delivery vector","volume":"8","author":"Chao","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.4049\/jimmunol.166.9.5346","article-title":"Papillomavirus-like particles induce acute activation of dendritic cells","volume":"166","author":"Lenz","year":"2001","journal-title":"J. Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.copbio.2004.10.005","article-title":"Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs","volume":"15","author":"Felnerova","year":"2004","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.immuni.2011.01.015","article-title":"Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges","volume":"34","author":"Bomsel","year":"2011","journal-title":"Immunity"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.addr.2004.09.005","article-title":"Virosomes for antigen and DNA delivery","volume":"57","author":"Daemen","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ijbiomac.2021.04.005","article-title":"Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review","volume":"182","author":"Asadi","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Pinnapireddy, S.R., Raafat El Assy, M., Schlote, P., and Bakowsky, U. (2019). Glycosylated artificial virus-like hybrid vectors for advanced gene delivery. Polymers, 11.","DOI":"10.3390\/polym11020243"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1166\/jbn.2017.2441","article-title":"Virus envelope-like self-assembled nanoparticles based on \u03b1-CD\/PEG for antigens targeting to dendritic cells","volume":"13","author":"Li","year":"2017","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1904958","DOI":"10.1002\/adma.201904958","article-title":"Bioinspired artificial tobacco mosaic virus with combined oncolytic properties to completely destroy multidrug-resistant cancer","volume":"32","author":"Wu","year":"2020","journal-title":"Adv. Mater."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.7150\/thno.35353","article-title":"Targeted delivery of cisplatin-derived nanoprecursors via a biomimetic yeast microcapsule for tumor therapy by the oral route","volume":"9","author":"Zhou","year":"2019","journal-title":"Theranostics"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2016.09.007","article-title":"Bioengineered and biohybrid bacteria-based systems for drug delivery","volume":"106","author":"Hosseinidoust","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1007\/s00253-013-4926-6","article-title":"Engineering of bacterial strains and their products for cancer therapy","volume":"97","author":"Bernardes","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0297-0","article-title":"Bacteria-cancer interactions: Bacteria-based cancer therapy","volume":"51","author":"Duong","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.0408422102","article-title":"Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1099\/00221287-148-4-923","article-title":"Genetically programmed autoinducer destruction reduces virulence gene expression and swarming motility in Pseudomonas aeruginosa PAO1The GenBank accession number for the aiiA nucleotide sequence is AF397400. The GenBank accession numbers for the nucleotide sequences of the 16S rRNA genes of strains A23 and A24 are AF397398 and AF397399","volume":"148","author":"Reimmann","year":"2002","journal-title":"Microbiology"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.7150\/ijms.6960","article-title":"Salmonella typhimurium mediated delivery of apoptin in human laryngeal cancer","volume":"10","author":"Guan","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/sj.bjc.6605403","article-title":"Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice","volume":"101","author":"Ganai","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1073\/pnas.0931258100","article-title":"A sensitive, versatile microfluidic assay for bacterial chemotaxis","volume":"100","author":"Mao","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"023902","DOI":"10.1063\/1.2431454","article-title":"Bacterial flagella-based propulsion and on\/off motion control of microscale objects","volume":"90","author":"Behkam","year":"2007","journal-title":"Appl. Phys. Lett."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"11403","DOI":"10.1038\/srep11403","article-title":"pH-taxis of biohybrid microsystems","volume":"5","author":"Zhuang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bpj.2012.09.005","article-title":"Bacterial thermotaxis by speed modulation","volume":"103","author":"Demir","year":"2012","journal-title":"Biophys. J."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"15155","DOI":"10.1073\/pnas.251543698","article-title":"Combination bacteriolytic therapy for the treatment of experimental tumors","volume":"98","author":"Dang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.gendis.2016.01.003","article-title":"Clostridium novyi-NT in cancer therapy","volume":"3","author":"Staedtke","year":"2016","journal-title":"Genes Dis."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/bit.20883","article-title":"Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro","volume":"94","author":"Kasinskas","year":"2006","journal-title":"Biotechnol. Bioeng."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"eaar4423","DOI":"10.1126\/scirobotics.aar4423","article-title":"Soft erythrocyte-based bacterial microswimmers for cargo delivery","volume":"3","author":"Alapan","year":"2018","journal-title":"Sci. Robot."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/14760584.2020.1777862","article-title":"The development of ghost vaccines trials","volume":"19","author":"Batah","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/biot.201400395","article-title":"Outer membrane vesicles as platform vaccine technology","volume":"10","author":"Stork","year":"2015","journal-title":"Biotechnol. J."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0168-1656(95)00123-9","article-title":"Bacterial ghosts: Non-living candidate vaccines","volume":"44","author":"Szostak","year":"1996","journal-title":"J. Biotechnol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.addr.2005.01.027","article-title":"Bacterial ghosts as antigen delivery vehicles","volume":"57","author":"Mayr","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/j.vaccine.2018.06.016","article-title":"Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines","volume":"36","author":"Darinskas","year":"2018","journal-title":"Vaccine"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrmicro3525","article-title":"Outer-membrane vesicles from Gram-negative bacteria: Biogenesis and functions","volume":"13","author":"Schwechheimer","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41579-018-0112-2","article-title":"Types and origins of bacterial membrane vesicles","volume":"17","author":"Toyofuku","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jconrel.2020.04.031","article-title":"Bacterial outer membrane vesicles as a platform for biomedical applications: An update","volume":"323","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/nl504798g","article-title":"Modulating antibacterial immunity via bacterial membrane-coated nanoparticles","volume":"15","author":"Gao","year":"2015","journal-title":"Nano Lett."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"41138","DOI":"10.1021\/acsami.0c13169","article-title":"Bacterial vesicle-cancer cell hybrid membrane-coated nanoparticles for tumor specific immune activation and photothermal therapy","volume":"12","author":"Wang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3934\/microbiol.2020001","article-title":"Saccharomyces cerevisiae and its industrial applications","volume":"6","author":"Parapouli","year":"2020","journal-title":"AIMS Microbiol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ni1408","article-title":"Dectin-1 is required for \u03b2-glucan recognition and control of fungal infection","volume":"8","author":"Taylor","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17425247.2019.1551874","article-title":"Yeast-inspired drug delivery: Biotechnology meets bioengineering and synthetic biology","volume":"16","author":"Sabu","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.mattod.2017.05.006","article-title":"Bioinspired yeast microcapsules loaded with self-assembled nanotherapies for targeted treatment of cardiovascular disease","volume":"20","author":"Zhang","year":"2017","journal-title":"Mater. Today"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour\u2014Targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2104139","DOI":"10.1002\/adma.202104139","article-title":"Engineering Nano-and Microparticles as Oral Delivery Vehicles to Promote Intestinal Lymphatic Drug Transport","volume":"33","author":"Miao","year":"2021","journal-title":"Adv. Mater."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/EC.1.5.657-662.2002","article-title":"Life and death in a macrophage: Role of the glyoxylate cycle in virulence","volume":"1","author":"Lorenz","year":"2002","journal-title":"Eukaryot. Cell"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2001212","DOI":"10.1002\/adhm.202001212","article-title":"Self-Propelled Micro\/Nanomotors for Tumor Targeting Delivery and Therapy","volume":"10","author":"Lin","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1021\/acsnano.5b07771","article-title":"From nanomotors to micromotors: The influence of the size of an autonomous bubble-propelled device upon its motion","volume":"10","author":"Wang","year":"2016","journal-title":"Acs Nano"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/anie.201406096","article-title":"Chemically powered micro-and nanomotors","volume":"54","author":"Soler","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.nantod.2013.08.009","article-title":"Small power: Autonomous nano-and micromotors propelled by self-generated gradients","volume":"8","author":"Wang","year":"2013","journal-title":"Nano Today"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1606301","DOI":"10.1002\/adma.201606301","article-title":"Spermatozoa as functional components of robotic microswimmers","volume":"29","author":"Magdanz","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1700160","DOI":"10.1002\/adbi.201700160","article-title":"Chemotactic guidance of synthetic organic\/inorganic payloads functionalized sperm micromotors","volume":"2","author":"Chen","year":"2018","journal-title":"Adv. Biosyst."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1021\/acsnano.9b07851","article-title":"Sperm micromotors for cargo delivery through flowing blood","volume":"14","author":"Xu","year":"2020","journal-title":"ACS Nano"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"58382","DOI":"10.1021\/acsami.1c18597","article-title":"Multifunctional Metal\u2013Organic Framework Exoskeletons Protect Biohybrid Sperm Microrobots for Active Drug Delivery from the Surrounding Threats","volume":"13","author":"Chen","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1021\/acsnano.6b02518","article-title":"Rocket science at the nanoscale","volume":"10","author":"Li","year":"2016","journal-title":"ACS Nano"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/5\/1109\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:17:00Z","timestamp":1760138220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/5\/1109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":202,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["pharmaceutics14051109"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14051109","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]}}}